| Literature DB >> 33578969 |
Masafumi Funamoto1,2, Yoichi Sunagawa1,2,3, Yasufumi Katanasaka1,2,3, Kana Shimizu1,2, Yusuke Miyazaki1,2,3, Nurmila Sari1, Satoshi Shimizu1,2, Kiyoshi Mori3, Hiromichi Wada2, Koji Hasegawa1,2, Tatsuya Morimoto1,2,3.
Abstract
Histone acetylation by epigenetic regulators has been shown to activate the transcription of hypertrophic response genes, which subsequently leads to the development and progression of heart failure. However, nothing is known about the acetylation of the histone tail and globular domains in left ventricular hypertrophy or in heart failure. The acetylation of H3K9 on the promoter of the hypertrophic response gene was significantly increased in the left ventricular hypertrophy stage, whereas the acetylation of H3K122 did not increase in the left ventricular hypertrophy stage but did significantly increase in the heart failure stage. Interestingly, the interaction between the chromatin remodeling factor BRG1 and p300 was significantly increased in the heart failure stage, but not in the left ventricular hypertrophy stage. This study demonstrates that stage-specific acetylation of the histone tail and globular domains occurs during the development and progression of heart failure, providing novel insights into the epigenetic regulatory mechanism governing transcriptional activity in these processes.Entities:
Keywords: BRG1; H3K122; H3K9; acetylation; cardiac hypertrophy; heart failure; histone; p300
Mesh:
Substances:
Year: 2021 PMID: 33578969 PMCID: PMC7916721 DOI: 10.3390/ijms22041771
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923